Sorrento Therapeutics Stock Price (NASDAQ:SRNE)

Add to My Stocks
$9.05 $0.25 (2.84%) SRNE stock closing price Feb 21, 2018 (Closing)
Prev Close* : $8.8
Market Cap:
$727.7M
Day Low: $8.85
52 Week Low: $1.50
Open: $8.9
Volume: -
Day High: $9.38
52 Week High: $9.55
Dividend:
0.00

Latest Stock Market News

Latest Articles

Sorrento Therapeutics News - From Partners

SRNE Stockcharts

View SRNE PE ratio, PS ratio stocks charts and compare with peers.
SRNE Chart
Note: Compare Sorrento Therapeutics stock price history with the index and industry peers.

Sorrento Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
4.7
PB ratio (
price to book ratio
)
6.98

Sorrento Therapeutics Returns

ROE
(return on equity)
-23%

Sorrento Therapeutics Financial Ratios

Asset Turnover
1.12
Receivables Turnover
42.05
Debt to Equity
0.2
Dividend Yield
0%

SRNE Industry Peers

Company Price Change (%)
Nucana Plc-adr (NCNA)20.270.29 (1.45%)
Beyondsprng Inc (BYSI)26.250.1 (0.38%)
Evotec (EVTCY)36.480 (0%)
Bristol-myers Squibb (BMY)66.530.82 (1.22%)
Receptos (RCPT)231.960.03 (0.01%)
Cotinga Pharma (COTQF)0.580 (0%)
Intrexon (XON)12.850.01 (0.08%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fate Therapeutics (FATE)10.591.42 (15.49%)
NeoGenomics (NEO)8.080.72 (9.78%)
Sunesis Pharma (SNSS)6.990.62 (9.73%)
Compugen (CGEN)3.250.2 (6.56%)
Fortress Biotech (FBIO)3.630.21 (6.14%)
Alder BioPharma (ALDR)14.550.7 (5.05%)
Stemline Therapeutics (STML)16.550.75 (4.75%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018
CompanyPriceChange (%)
GTx (GTXI)15.461.25 (7.48%)
Catalyst Biosciences (CBIO)27.541.96 (6.64%)
Five Prime Therapeutics (FPRX)17.681.21 (6.41%)
Arbutus Biopharma (ABUS)5.250.25 (4.55%)
Ultragenyx Pharma (RARE)46.311.87 (3.88%)
MediciNova (MNOV)10.610.4 (3.63%)
The Medicines Company (MDCO)31.621.18 (3.6%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018

Sorrento Therapeutics Inc Stock News - Partner Headlines

Sorrento Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues8.15M4.59M3.82M--
Net Income-60.92M-45.81M-34.65M-21.91M-4.84M
Total Operating Expense103.26M76.63M36.51M21.31M5.43M
View Sorrento Therapeutics income statement
balance sheet20162015201420132012
Total Assets401.58M343.51M141.54M92.58M6.78M
Total Liabilities315.08M202.58M32.82M25.77M-
Shareholders Equity86.5M140.93M108.71M66.8M6.19M
View Sorrento Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities25.6M14.8M-0.22M--0.1M
Net Cash from (used by) Operating Activities-70.89M-42.06M-28.76M-16.48M-3.79M
Increase (Decrease) in Prop Plant And Equipment-6.86M-3.7M-0.59M-0.42M-0.54M
View Sorrento Therapeutics cash flow statement

Sorrento Therapeutics Stock Message Board

An investor needs to spend $9.05 to buy SRNE stock, as the closing Sorrento Therapeutics stock price is $9.05. The total market value as denoted by $727.7M for Sorrento Therapeutics, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Sorrento Therapeutics valuation, even though in the short-term, sentiment and current breaking news might affect Sorrento Therapeutics stock price.

For recognizing and analyzing the real performance of Sorrento Therapeutics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Sorrento Therapeutics stock quote data shows the number of shares traded. For Ex: 2,732,182 Sorrento Therapeutics shares were traded as of last trading day, as seen from Sorrento Therapeutics stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Sorrento Therapeutics stock dividend was 0.00 during the last quarter. Sorrento Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.